SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 115 filers reported holding SUTRO BIOPHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,685,802 | -25.0% | 485,822 | +0.6% | 0.00% | – |
Q2 2023 | $2,246,285 | +6.9% | 483,072 | +6.2% | 0.00% | – |
Q1 2023 | $2,101,671 | -43.5% | 454,907 | -1.2% | 0.00% | -100.0% |
Q4 2022 | $3,721,349 | +64.8% | 460,563 | +13.2% | 0.00% | 0.0% |
Q3 2022 | $2,258,000 | +15.0% | 406,772 | +7.9% | 0.00% | – |
Q2 2022 | $1,964,000 | -38.9% | 376,980 | -3.6% | 0.00% | -100.0% |
Q1 2022 | $3,214,000 | -60.4% | 391,024 | -28.3% | 0.00% | 0.0% |
Q4 2021 | $8,112,000 | -19.9% | 545,224 | +1.7% | 0.00% | -50.0% |
Q3 2021 | $10,126,000 | -1.7% | 536,024 | -3.3% | 0.00% | 0.0% |
Q2 2021 | $10,306,000 | +31.5% | 554,399 | +61.0% | 0.00% | +100.0% |
Q1 2021 | $7,837,000 | +14.9% | 344,321 | +9.6% | 0.00% | 0.0% |
Q4 2020 | $6,822,000 | +207.4% | 314,276 | +42.3% | 0.00% | – |
Q3 2020 | $2,219,000 | +30.5% | 220,809 | +0.8% | 0.00% | – |
Q2 2020 | $1,701,000 | +30.6% | 219,150 | +71.6% | 0.00% | – |
Q1 2020 | $1,302,000 | -3.1% | 127,682 | +4.5% | 0.00% | – |
Q4 2019 | $1,344,000 | +21.8% | 122,180 | +0.6% | 0.00% | – |
Q3 2019 | $1,103,000 | +21.6% | 121,424 | +52.2% | 0.00% | – |
Q2 2019 | $907,000 | +6.5% | 79,777 | +6.6% | 0.00% | – |
Q1 2019 | $852,000 | +46.9% | 74,867 | +16.4% | 0.00% | – |
Q4 2018 | $580,000 | – | 64,316 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 1,675,579 | $13,773,000 | 3.47% |
AJU IB Investment Co., Ltd. | 175,000 | $1,439,000 | 2.22% |
Frazier Life Sciences Management, L.P. | 1,776,479 | $14,603,000 | 1.24% |
First Light Asset Management, LLC | 1,672,497 | $13,748,000 | 1.21% |
BVF INC/IL | 3,447,946 | $28,342,000 | 1.13% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,732,400 | $30,680,000 | 0.94% |
Endurant Capital Management LP | 296,508 | $2,437,000 | 0.64% |
Parkman Healthcare Partners LLC | 199,846 | $1,643,000 | 0.48% |
Eventide Asset Management | 2,708,975 | $22,268,000 | 0.35% |
Lombard Odier Asset Management (Switzerland) SA | 391,024 | $3,214,000 | 0.25% |